Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study

Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study

The aim of this study was to determine whether metabolic tumor volume (MTV) and total lesion glycolysis (TLG) are associated with outcomes in Stage I lung cancer patients treated with stereotactic body radiation therapy (SBRT). Thirty-eight patients underwent [18F] fluorodeoxyglucose positron emissi...

Full description

Bibliographic Details
Main Authors: Takahashi, Noriyoshi, Yamamoto, Takaya, Matsushita, Haruo, Sugawara, Toshiyuki, Kubozono, Masaki, Umezawa, Rei, Ishikawa, Yojiro, Kozumi, Maiko, Katagiri, Yu, Tasaka, Syun, Takeda, Kazuya, Takeda, Ken, Dobashi, Suguru, Jingu, Keiichi
Format: Online
Language:English
Published: Oxford University Press 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137288/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137288/

Similar Items